Ftse Mib
35.390,52
-0,06%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.831,93
2,44%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Addex Therapeutics Ltd (ADXN) Addex Therapeutics Ltd (ADXN) Notizie

ADXN

Addex Therapeutics (ADXN)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADXN
DataOraFonteTitoloSimboloCompagnia
08/05/202407:00GlobeNewswire Inc.Addex to Present at Bio€quity Europe 2024NASDAQ:ADXNAddex Therapeutics Ltd
29/04/202407:00GlobeNewswire Inc.Addex Provides Update on ADX71149 Phase 2 Epilepsy StudyNASDAQ:ADXNAddex Therapeutics Ltd
19/04/202407:00GlobeNewswire Inc.Addex to Present at the Swiss Biotech Day 2024NASDAQ:ADXNAddex Therapeutics Ltd
18/04/202407:00GlobeNewswire Inc.Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
11/04/202407:00GlobeNewswire Inc.Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024NASDAQ:ADXNAddex Therapeutics Ltd
03/04/202407:00GlobeNewswire Inc.Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological DisordersNASDAQ:ADXNAddex Therapeutics Ltd
14/03/202407:00GlobeNewswire Inc.Addex to Present at the Bio-Europe Spring 2024 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
31/01/202407:00GlobeNewswire Inc.Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202423:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ADXNAddex Therapeutics Ltd
30/01/202422:58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ADXNAddex Therapeutics Ltd
09/01/202407:00GlobeNewswire Inc.Addex to Present at the Swiss Equities Baader ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/01/202407:30GlobeNewswire Inc.Addex to Present at Biotech Showcase™ 2024NASDAQ:ADXNAddex Therapeutics Ltd
21/12/202312:00Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
20/12/202307:00GlobeNewswire Inc.Addex Shareholders Approve All Resolutions at Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
14/12/202307:00GlobeNewswire Inc.Addex Creates Treasury SharesNASDAQ:ADXNAddex Therapeutics Ltd
08/12/202320:11Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ADXNAddex Therapeutics Ltd
30/11/202322:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ADXNAddex Therapeutics Ltd
30/11/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ADXNAddex Therapeutics Ltd
29/11/202312:27Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:ADXNAddex Therapeutics Ltd
29/11/202307:00GlobeNewswire Inc.Addex Reports Q3 2023 Financial Results and Provides Corporate UpdateNASDAQ:ADXNAddex Therapeutics Ltd
28/11/202307:00GlobeNewswire Inc.Addex Convenes Extraordinary General MeetingNASDAQ:ADXNAddex Therapeutics Ltd
23/11/202307:00GlobeNewswire Inc.Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023NASDAQ:ADXNAddex Therapeutics Ltd
14/11/202307:00GlobeNewswire Inc.Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of PatientsNASDAQ:ADXNAddex Therapeutics Ltd
08/11/202307:00GlobeNewswire Inc.Addex Regains Nasdaq Listing ComplianceNASDAQ:ADXNAddex Therapeutics Ltd
02/11/202307:00GlobeNewswire Inc.Addex Announces Participation in the Bio-Europe 2023 ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
20/10/202307:00GlobeNewswire Inc.Addex Completes ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
06/10/202322:00GlobeNewswire Inc.Addex Announces Plan to Implement ADS Ratio ChangeNASDAQ:ADXNAddex Therapeutics Ltd
20/09/202307:00GlobeNewswire Inc.Addex mGlu2 NAM Cognition Program Receives €4 Million GrantNASDAQ:ADXNAddex Therapeutics Ltd
06/09/202307:00GlobeNewswire Inc.Addex Announces Participation in the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:ADXNAddex Therapeutics Ltd
05/09/202307:00GlobeNewswire Inc.Addex ADX71149 Phase 2 Epilepsy Study Expected to Readout Data in Q2 2024NASDAQ:ADXNAddex Therapeutics Ltd
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:ADXN

La tua Cronologia

USOTC
EMOTF
Emerita Resources (QB)
BIT
UB5LYK
Unicredit Bank
BIT
UC6FWA
Unicredit Bank
COIN
HOTTUST
Hydro Protocol
COIN
ACATEUR
Alphacat
LSE
UK3L
Etfs 3x Uk100
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network